Evidence map›Paper›PMID 28395670›Full record

ArticleSkeletal muscle2017

Absence of physiological Ca

Chehade Karam, Jianxun Yi, Yajuan Xiao, Kamal Dhakal, Lin Zhang, Xuejun Li, Carlo Manno, Jiejia Xu, Kaitao Li, Heping Cheng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Skeletal muscle, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 41 citations in OpenAlex.

  1. The two faces of mitochondrial CaJournal of physiology and biochemistry · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Disuse-Induced Muscle Fatigue: Facts and Assumptions.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Old and new biomarkers for volumetric muscle loss.Current opinion in pharmacology · 2021
    Review
  18. Article
  19. Altered CaMetabolites · 2021
    Review
  20. CaNeuroscience letters · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Chehade KaramRush University School of Medicine, Chicago, IL, USA.
Jianxun YiRush University School of Medicine, Chicago, IL, USA.
Yajuan XiaoRush University School of Medicine, Chicago, IL, USA.
Kamal DhakalKansas City University of Medicine and Bioscience, 1750 Independence Ave, Kansas City, MO, 64106, USA.
Lin ZhangRush University School of Medicine, Chicago, IL, USA.
Xuejun LiKansas City University of Medicine and Bioscience, 1750 Independence Ave, Kansas City, MO, 64106, USA.
Carlo MannoRush University School of Medicine, Chicago, IL, USA.
Jiejia XuInstitute of Molecular Medicine, Peking University, Beijing, China.
Kaitao LiInstitute of Molecular Medicine, Peking University, Beijing, China.
Heping ChengInstitute of Molecular Medicine, Peking University, Beijing, China.
Jianjie MaWexner Medical Center, The Ohio State University, 460 West 12th Avenue, Columbus, OH, USA. jianjie.ma@osumc.edu.
Jingsong ZhouRush University School of Medicine, Chicago, IL, USA. jzhou@kcumb.edu.ORCID 0000-0002-5684-7177
Kansas City University · USPeking University · CNRush University · USThe Ohio State University Wexner Medical Center · US

Funding

TRAINING IN CELLULAR SIGNALLING IN THE CARDIOVASCULAR SYT32HL007692 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SOLARO, R JOHN · 1990 to 2014
$8.5M
Ca Sparks in Muscle Aging and DystrophyR01AG028614 · NIA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MA, JIANJIE · 2006 to 2016
$4.1M
Ca Signaling in Progression of Amyotrophic Lateral Sclerosis in Skeletal MuscleR01AR057404 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI ZHOU, JINGSONG · 2010 to 2014
$1.6M
NHLBI NIH HHS T32 HL007692NIAMS NIH HHS R01 AR057404NIA NIH HHS R01 AG028614
6 · The paper itself

Abstract

backgroundMotor neurons control muscle contraction by initiating action potentials in muscle. Denervation of muscle from motor neurons leads to muscle atrophy, which is linked to mitochondrial dysfunction. It is known that denervation promotes mitochondrial reactive oxygen species (ROS) production in muscle, whereas the initial cause of mitochondrial ROS production in denervated muscle remains elusive. Since denervation isolates muscle from motor neurons and deprives it from any electric stimulation, no action potentials are initiated, and therefore, no physiological Ca

methodsA transgenic mouse model expressing a mitochondrial targeted biosensor (mt-cpYFP) allowed a real-time measurement of the ROS-related mitochondrial metabolic function following denervation, termed "mitoflash." Using live cell imaging, electrophysiological, pharmacological, and biochemical studies, we examined a potential molecular mechanism that initiates ROS-related mitochondrial dysfunction following denervation.

resultsWe found that muscle fibers showed a fourfold increase in mitoflash activity 24 h after denervation. The denervation-induced mitoflash activity was likely associated with an increased activity of mitochondrial permeability transition pore (mPTP), as the mitoflash activity was attenuated by application of cyclosporine A. Electrical stimulation rapidly reduced mitoflash activity in both sham and denervated muscle fibers. We further demonstrated that the Ca

conclusionsThe loss of cytosolic Ca

Indexed as

Calcium SignalingAction PotentialsAnimalsExcitation Contraction CouplingMiceMitochondria, MuscleMuscle DenervationMuscle, SkeletalReactive Oxygen SpeciesReactive Oxygen SpeciesCalcium imagingCalcium intracellular releaseCalcium signalingDenervationE-C couplingMitochondria

Identifiers

PMID28395670
PMCPMC5387329
OpenAlexW2607469737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.